Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.98 USD
Change Today -0.13 / -4.18%
Volume 129.2K
BTX On Other Exchanges
BTX is not on other exchanges.
As of 8:04 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. West Ph.D.

Chief Executive Officer, President and Director,BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 6 different organizations across 11 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael D. West, also known as Mike, Ph.D., has been Vice President of Technology Integration at Asterias Biotherapeutics, Inc. since March 2013. Dr. West has been the Chief Executive Officer of BioTime, Inc. since October 10, 2007 and also serves as its President. Dr. West serves as the Chief Scientific Officer of LifeMap Sciences, Inc. He serves as the Chief Executive Officer of Embryome Sciences, Inc. He served as Interim Chief Executive Officer and President ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Chief Executive Officer of Biotime, Inc. and Director
Chairman of The Board
Chief Scientific Officer, Director and Chief Executive Officer of BioTime Inc
Chief Executive Officer, President and Director
Vice President of Technology Integration and Director


PhD 1989
Baylor College of Medicine
BS 1976
Rensselaer Polytechnic Institute
MS 1982
Andrews University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$884,315

Stock Options*

All Other Compensation$38,000
Exercisable Options137,500
Unexercisable Options262,500
Total Number of Options400,000

Total Compensation*

Total Annual Cash Compensation$922,315
Total Short Term Compensation$884,315
Other Long Term Compensation$38,000
Total Calculated Compensation$1,546,430
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $2.98 USD -0.13


Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Ocata Therapeutics, Inc.
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
Yokoyama Chikafumi Ph.D.Chief Executive Officer, President and Representative Director
ReproCELL, Inc.
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at